COVID-19: New FDA guidance allows use of KardiaMobile 6L to measure QTc in virus patients

Kardia 6L AliveCor’s KardiaMobile 6L—the world’s only six lead personal ECG—is now allowed for use in the measurement of a patient’s QTc and detection of potentially dangerous QT prolongation.  A prolonged QTc can lead to a potentially fatal side effect, which is associated with the use of several medicines now being used [...]

2020-03-30T10:19:17+00:00March 30th, 2020|Tags: , , |

AliveCor and Huami announce a “multi-faceted global strategic alliance”

KardiaMobile AliveCor and Huami have come together to create a multi-faceted global strategic alliance, according to a press release, that combines the technologies of each company to deliver a new generation of medical functionality to wearable devices. The press release reports that the agreement encompasses the licensing of AliveCor technology and an [...]

2019-11-05T10:34:51+00:00November 4th, 2019|Tags: , , , |

UC San Francisco’s Health Hub reveals winners of its Digital Health Awards

AliveCor receiving their award UC San Francisco’s Health Hub—an innovation hub and startup studio supporting the next wave of digital health entrepreneurs—has announced the winners of its Digital Health Awards. A press release reports that this awards event celebrates the achievements of innovative companies dramatically improving healthcare with technology. The winners were [...]

2019-10-21T14:01:53+00:00October 21st, 2019|Tags: , |
Go to Top